References analysis of the Wikipedia article "Properdin" in the English version

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

Kemper C, Mitchell LM, Zhang L, Hourcade DE (July 2008). "The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis". Proceedings of the National Academy of Sciences of the United States of America. 105 (26): 9023–9028. Bibcode:2008PNAS..105.9023K. doi:10.1073/pnas.0801015105. PMC 2449358. PMID 18579773.

Goundis D, Reid KB (September 1988). "Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs". Nature. 335 (6185): 82–85. Bibcode:1988Natur.335...82G. doi:10.1038/335082a0. PMID 3045564.

Yang Y, Liu F, Franc V, Halim LA, Schellekens H, Heck AJ (November 2016). "Hybrid mass spectrometry approaches in glycoprotein analysis and their usage in scoring biosimilarity". Nature Communications. 7 (1) 13397. Bibcode:2016NatCo...713397Y. doi:10.1038/ncomms13397. PMC 5105167. PMID 27824045.

Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. (October 2006). "The consensus coding sequences of human breast and colorectal cancers". Science. 314 (5797). New York, N.Y.: 268–274. Bibcode:2006Sci...314..268S. doi:10.1126/science.1133427. PMID 16959974.

doi.org (Global: 2^nd place; English: 2^nd place)

Camous L, Roumenina L, Bigot S, Brachemi S, Frémeaux-Bacchi V, Lesavre P, et al. (January 2011). "Complement alternative pathway acts as a positive feedback amplification of neutrophil activation". Blood. 117 (4): 1340–1349. doi:10.1182/blood-2010-05-283564. PMID 21063021.

Whaley K (March 1980). "Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes". The Journal of Experimental Medicine. 151 (3): 501–516. doi:10.1084/jem.151.3.501. PMC 2185797. PMID 6444659.

Carroll MV, Sim RB (September 2011). "Complement in health and disease". Advanced Drug Delivery Reviews. Complement Monotoring of Nanomedicines and Implants. 63 (12): 965–975. doi:10.1016/j.addr.2011.06.005. PMID 21704094.

Smith C, Pangburn M, Vogel CW, Müller-Eberhard H (1984). "Molecular Architecture of Human Properdin, a Positive Regulator of the Alternative Pathway of Complement". The Journal of Biological Chemistry. 259 (7): R4582–4588. doi:10.1016/S0021-9258(17)43086-9. PMID 6707020.

Pangburn MK (January 1989). "Analysis of the natural polymeric forms of human properdin and their functions in complement activation". Journal of Immunology. 142 (1). Baltimore: 202–207. doi:10.4049/jimmunol.142.1.202. PMID 2909614.

Hartmann S, Hofsteenge J (September 2000). "Properdin, the positive regulator of complement, is highly C-mannosylated". The Journal of Biological Chemistry. 275 (37): 28569–28574. doi:10.1074/jbc.m001732200. PMID 10878002.

Hourcade DE (January 2006). "The role of properdin in the assembly of the alternative pathway C3 convertases of complement". The Journal of Biological Chemistry. 281 (4): 2128–2132. doi:10.1074/jbc.m508928200. PMID 16301317.

Zaferani A, Vivès RR, van der Pol P, Navis GJ, Daha MR, van Kooten C, et al. (September 2012). "Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate". The Journal of Biological Chemistry. 287 (37): 31471–31481. doi:10.1074/jbc.M112.380386. PMC 3438980. PMID 22815489.

Kimura Y, Miwa T, Zhou L, Song WC (January 2008). "Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement". Blood. 111 (2): 732–740. doi:10.1182/blood-2007-05-089821. PMC 2200840. PMID 17916747.

Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE (August 2007). "Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly". Journal of Immunology. 179 (4). Baltimore: 2600–2608. doi:10.4049/jimmunol.179.4.2600. PMID 17675523.

Uchiyama S, Keller N, Schlaepfer E, Grube C, Schuepbach RA, Speck RF, et al. (July 2016). "Interferon α-Enhanced Clearance of Group A Streptococcus Despite Neutropenia". The Journal of Infectious Diseases. 214 (2): 321–328. doi:10.1093/infdis/jiw157. PMID 27338768.

Dixon KO, O'Flynn J, Klar-Mohamad N, Daha MR, van Kooten C (March 2017). "Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ". European Journal of Immunology. 47 (3): 470–480. doi:10.1002/eji.201646703. PMC 5363362. PMID 28105653.

Schwaeble W, Dippold WG, Schäfer MK, Pohla H, Jonas D, Luttig B, et al. (September 1993). "Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells". Journal of Immunology. 151 (5). Baltimore: 2521–2528. doi:10.4049/jimmunol.151.5.2521. PMID 8360474.

Stover CM, Luckett JC, Echtenacher B, Dupont A, Figgitt SE, Brown J, et al. (March 2008). "Properdin plays a protective role in polymicrobial septic peritonitis". Journal of Immunology. 180 (5). Baltimore: 3313–3318. doi:10.4049/jimmunol.180.5.3313. PMID 18292556.

Wirthmueller U, Dewald B, Thelen M, Schäfer MK, Stover C, Whaley K, et al. (May 1997). "Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils". Journal of Immunology. 158 (9). Baltimore: 4444–4451. doi:10.4049/jimmunol.158.9.4444. PMID 9127010.

Reis ES, Barbuto JA, Isaac L (May 2006). "Human monocyte-derived dendritic cells are a source of several complement proteins". Inflammation Research. 55 (5): 179–184. doi:10.1007/s00011-006-0068-y. PMID 16830104.

Pattrick M, Luckett J, Yue L, Stover C (February 2009). "Dual role of complement in adipose tissue". Molecular Immunology. 46 (5): 755–760. doi:10.1016/j.molimm.2008.09.013. PMID 18954909.

Jeon H, Yoo SM, Choi HS, Mun JY, Kang HG, Lee J, et al. (November 2017). "Extracellular vesicles from KSHV-infected endothelial cells activate the complement system". Oncotarget. 8 (59): 99841–99860. doi:10.18632/oncotarget.21668. PMC 5725135. PMID 29245944.

Bongrazio M, Pries AR, Zakrzewicz A (January 2003). "The endothelium as physiological source of properdin: role of wall shear stress". Molecular Immunology. 39 (11): 669–675. doi:10.1016/S0161-5890(02)00215-8. PMID 12493642.

Gauvreau D, Roy C, Tom FQ, Lu H, Miegueu P, Richard D, et al. (May 2012). "A new effector of lipid metabolism: complement factor properdin". Molecular Immunology. 7th International EMBO Workshop on Antigen Presentation and Processing. 51 (1): 73–81. doi:10.1016/j.molimm.2012.02.110. PMID 22387270.

Andrades JA, Nimni ME, Becerra J, Eisenstein R, Davis M, Sorgente N (September 1996). "Complement proteins are present in developing endochondral bone and may mediate cartilage cell death and vascularization". Experimental Cell Research. 227 (2): 208–213. doi:10.1006/excr.1996.0269. PMID 8831558.

Mayatepek E, Grauer M, HäNsch GM, Sonntag HG (October 1993). "Deafness, complement deficiencies and immunoglobulin status in patients with meningococcal diseases due to uncommon serogroups". The Pediatric Infectious Disease Journal. 12 (10): 808–811. doi:10.1097/00006454-199310000-00002. PMID 8284115.

SjÖHolm AG (October 1990). "Inherited complement deficiency states: implications for immunity and immunological disease". Apmis. 98 (10): 861–874. doi:10.1111/j.1699-0463.1990.tb05008.x. PMID 2147105.

Fijen CA, van den Bogaard R, Schipper M, Mannens M, Schlesinger M, Nordin FG, et al. (1999). "Properdin deficiency: molecular basis and disease association". Molecular Immunology. 36 (13–14): 863–867. doi:10.1016/S0161-5890(99)00107-8. PMID 10698340.

Pangburn MK, Müller-Eberhard HJ (1984). "The alternative pathway of complement". Springer Seminars in Immunopathology. 7 (2–3): 163–192. doi:10.1007/BF01893019. PMID 6238433.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Pattrick M, Luckett J, Yue L, Stover C (February 2009). "Dual role of complement in adipose tissue". Molecular Immunology. 46 (5): 755–760. doi:10.1016/j.molimm.2008.09.013. PMID 18954909.

Pangburn MK, Müller-Eberhard HJ (1984). "The alternative pathway of complement". Springer Seminars in Immunopathology. 7 (2–3): 163–192. doi:10.1007/BF01893019. PMID 6238433.

ncbi.nlm.nih.gov

Properdin (English Wikipedia)

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

ui.adsabs.harvard.edu

bioporto.com (Global: low place; English: low place)

doi.org (Global: 2^nd place; English: 2^nd place)

ensembl.org (Global: 630^th place; English: 326^th place)

may2017.archive.ensembl.org

figshare.com (Global: 3,822^nd place; English: 2,289^th place)

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

web.archive.org (Global: 1^st place; English: 1^st place)

Properdin (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

bioporto.com (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

ensembl.org (Global: 630th place; English: 326th place)

may2017.archive.ensembl.org

figshare.com (Global: 3,822nd place; English: 2,289th place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

web.archive.org (Global: 1st place; English: 1st place)

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

ensembl.org (Global: 630^th place; English: 326^th place)

figshare.com (Global: 3,822^nd place; English: 2,289^th place)

nih.gov (Global: 5^th place; English: 5^th place)

web.archive.org (Global: 1^st place; English: 1^st place)